Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05PNO
|
||||
Former ID |
DNC007185
|
||||
Drug Name |
1-(2-iodoethyl)-1H-indole-2,3-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C10H8INO2
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C(=O)N2CCI
|
||||
InChI |
1S/C10H8INO2/c11-5-6-12-8-4-2-1-3-7(8)9(13)10(12)14/h1-4H,5-6H2
|
||||
InChIKey |
OBYVXAUONRVYHA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Liver carboxylesterase | Target Info | Inhibitor | [1] | |
KEGG Pathway | Drug metabolism - other enzymes | ||||
Metabolic pathways | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
WikiPathways | NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | |||||
Heroin metabolism | |||||
Irinotecan Pathway | |||||
Fluoropyrimidine Activity | |||||
Phase I biotransformations, non P450 | |||||
References | |||||
REF 1 | J Med Chem. 2007 Apr 19;50(8):1876-85. Epub 2007 Mar 23.Selective inhibition of carboxylesterases by isatins, indole-2,3-diones. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.